Labshake search
Citations for GE Life Sciences :
1 - 50 of 1831 citations for Septin 1 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... After blocking in ECL blocking agent (GE Healthcare), membranes were probed with primary antibodies overnight at 4°C ...
-
bioRxiv - Cancer Biology 2021Quote: ... After blocking with 5% ECL Blocking Agent (GE Healthcare, RPN2125) at RT for 1 h ...
-
bioRxiv - Plant Biology 2022Quote: ... diluted 1:10,000 in 2% TBST with 2% Blocking (GE Healthcare), was applied for 1 h.
-
bioRxiv - Biochemistry 2021Quote: ... and 0.1% FA (Fluka) and crosslinked peptides were enriched by separation on a Superdex Peptide PC 3.2/30 column (GE Healthcare), using an Agilent 1100 chromatography system at 95 μL/minute with fraction collection ...
-
bioRxiv - Neuroscience 2024Quote: ... and incubated in Blocking Buffer containing 5 % Blocking for ECL (GE healthcare) in Tris buffer for two hours ...
-
bioRxiv - Molecular Biology 2020Quote: ... Peptides were separated using a Superdex Peptide 3.2/300 column (GE Healthcare) at a flow rate of 10 μl/minute ...
-
bioRxiv - Molecular Biology 2022Quote: ... Eluted peptides were fractionated using a Superdex Peptide 3.2/300 column (GE Healthcare) at a flow rate of 10 μl min−1 using 30% (v/v ...
-
bioRxiv - Neuroscience 2021Quote: ... anti-mouse or anti-rat secondary antibodies (1:4000 in blocking buffer, GE Healthcare) for 1 hour at room temperature ...
-
bioRxiv - Physiology 2019Quote: ... Upon blocking the membrane with 2% (w/v) Amersham ECL Prime Blocking Reagent (GE Healthcare) for an hour at room temperature ...
-
bioRxiv - Biochemistry 2021Quote: ... Eluted peptides were fractionated on a Superdex Peptide 3.2/300 increase column (GE Healthcare) at a flow rate of 10 µL/min using 30% (v/v ...
-
bioRxiv - Biochemistry 2022Quote: ... Eluted peptides were fractionated on a Superdex Peptide 3.2/300 increase column (GE Healthcare) at a flow rate of 10 µL/min using 30% (v/v ...
-
bioRxiv - Cancer Biology 2020Quote: ... Membranes were then blocked for 1 h with TBS-T 1% ECL Prime blocking reagent (GE Healthcare cat # RPN418) at RT on an orbital shaker and blotted with primary antibody for 1 h at RT with gentle agitation ...
-
bioRxiv - Plant Biology 2022Quote: ... The primary antibody was diluted 1:10,000 in TBST-Buffer with 2% Blocking (GE Healthcare) and incubated on the membrane for 2 h ...
-
bioRxiv - Biochemistry 2022Quote: EDC-crosslinked FERRY peptides were separated on a Superdex Peptide PC3.2/30 column (GE Healthcare) at a flow rate of 50 µL min−1 ...
-
bioRxiv - Cancer Biology 2022Quote: Size based fractionation of the peptides were done using Superdex Peptide 3.2/300 (GE Healthcare) column and HPLC (Agilent 1260 Infinity II) ...
-
bioRxiv - Biochemistry 2022Quote: ... Crosslinked peptides were enriched by size exclusion chromatography on a Superdex Peptide PC 3.2/30 column (GE Healthcare) using water/acetonitrile/TFA (77.4/22.5/0.1 ...
-
bioRxiv - Molecular Biology 2020Quote: ... blocked with 5% membrane blocking agent (GE Healthcare) in TBS and incubated with the corresponding primary antibody ...
-
bioRxiv - Cancer Biology 2021Quote: ... Secondary antibodies were diluted in blocking solution at 1:1000 (Anti-rabbit IgG: GE Healthcare Cat#NA934, RRID:AB_772206) and 1:2000 (Anti-mouse IgG ...
-
bioRxiv - Biophysics 2021Quote: ... Peptides were desalted on a C18 MacroTrap column (Michrom Bioresources) and fractionated on a Superdex Peptide (GE Life Sciences) size-exclusion column ...
-
bioRxiv - Biochemistry 2019Quote: ... 50 μg of peptides were fractionated in a Shimadzu HPLC system using a Superdex Peptide 3.2/300 (GE Healthcare) at a flow rate of 50 μl/min using SEC buffer (30% (v/v ...
-
bioRxiv - Molecular Biology 2021Quote: ... in water /0.1% (v/v) trifluoroacetic acid (TFA) and crosslinked peptides were enriched by peptide size exclusion chromatography (SuperdexPeptide 3.2/300 column, GE Healthcare) with a flow rate of 50 μl/ min in 30 % (v/v ...
-
bioRxiv - Neuroscience 2020Quote: ... treated with ECL prime blocking buffer (GE healthcare RPN418) for 1 hour and incubated with antibody at 4°C ...
-
bioRxiv - Cell Biology 2020Quote: ... a Superdex Peptide 3.2/300 column (GE Healthcare) with 30% (v/v ...
-
bioRxiv - Molecular Biology 2020Quote: ... using a Superdex Peptide 3.2/300 (GE Healthcare) at a flow rate of 10 ţl min1 using 30% (v/v ...
-
bioRxiv - Biochemistry 2020Quote: ... A Superdex Peptide 3.2/300 column (GE Healthcare) was used for SEC fractionation by isocratic elution with 30% (v/v ...
-
bioRxiv - Biochemistry 2023Quote: ... a Superdex Peptide 3.2/300 column (GE Healthcare) with 30% (v/v ...
-
bioRxiv - Biophysics 2020Quote: ... 100 μL of this peptide solution was subjected to SEC analysis by passing through Superdex peptide 10/300 GL column (GE healthcare) connected to Bio-Rad (Biologic Duoflow ...
-
bioRxiv - Physiology 2022Quote: ... The membrane was incubated for 1 hour at RT in 2% enhanced chemiluminiscence (ECL) prime blocking agent (GE Healthcare, RPN418). Membranes were incubated overnight at 4⁰C in blocking buffer (4% bovine serum albumin (BSA ...
-
bioRxiv - Molecular Biology 2022Quote: ... Peptides were eluted and fractionated by size exclusion chromatography (SEC) using a Superdex Peptide 3.2/300 column (GE Healthcare, Chicago, IL, USA) at a flow rate of 10 μl min−1 using 30% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Membranes were blocked in ECL advance blocking reagent (GE Healthcare) in TBS-Tween 0.1% and incubated with primary antibodies overnight at 4 °C ...
-
bioRxiv - Plant Biology 2020Quote: ... The membrane was blocked for 1 h at room temperature in TBS containing 4% Amersham ECL Prime Blocking Reagent (GE Healthcare) and 0.1% Tween 20 ...
-
bioRxiv - Biophysics 2020Quote: ... Fixed cells were rinsed three times in warm PBS and incubated 30 min with a blocking solution containing 1% BSA (Bovine Serum Albumine, GE Healthcare) and 5% FBS in PBS ...
-
bioRxiv - Biophysics 2023Quote: ... The fixed cells were rinsed three times in warm PBS and incubated for 30 min with a blocking solution containing 1% BSA (GE Healthcare) and 5% FBS in PBS ...
-
bioRxiv - Immunology 2019Quote: ... Both mutants carry a carboxy-terminal cmyc-peptide extension and a poly-His peptide extension for purification using nickel columns from GE Healthcare (Chicago, IL) and for anchoring in ELISAs as previously described and specified below (11–15).
-
bioRxiv - Neuroscience 2020Quote: ... which were then treated with ECL Prime blocking agent (GE Healthcare) and incubated with primary antibodies raised against the PS1 N-terminal (G1Nr5 ...
-
bioRxiv - Synthetic Biology 2020Quote: ... Blots were blocked with 2% ECL Prime blocking agent (GE Healthcare) in PBS-T (PBS buffer supplemented with 0.1% (v/v ...
-
bioRxiv - Biophysics 2021Quote: ... using a Superdex™ Peptide 3.2/300 column (GE Healthcare) at a flow rate of 50 µL/min of the mobile phase (water/acetonitrile/trifluoroacetic acid 70 %/30 %/0.1 % ...
-
bioRxiv - Molecular Biology 2020Quote: ... peptides were fractionated on an ÄKTA Pure system (GE Healthcare) using a Superdex Peptide 3.2/300 (GE Healthcare ...
-
bioRxiv - Physiology 2022Quote: ... at a dilution of 1:2000 was done for 1 hour at RT in blocking buffer and detection was done using ECL detection kit (RPN2235, GE Healthcare, USA). Images were taken by the ImageQuant LAS500 (GE healthcare ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... to a polyvinylidene difluoride membrane and blocked in TBST buffer (TBS with 0.1% (v/v) Tween-20) supplemented with 1% ECL Advance Blocking Agent (GE Healthcare, Waukesha, WI) for 40 minutes at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... plasma or CSF probes were incubated in 25 μl for 1 hour at room temperature (diluted with PBS containing 5% Amersham ECL Blocking Agent, GE Healthcare RNP2125), followed by additional washing steps and incubation with an anti-mouse secondary antibody conjugated with the MSD Sulfo-tag for detection ...
-
bioRxiv - Developmental Biology 2023Quote: ... Membranes were then washed in PBT and incubated with HRP conjugated-anti-rabbit IgG (GE Healthcare # NA9340, 1:5000 in blocking solution) at room temperature for 1 hour and washed twice in PBT ...
-
bioRxiv - Bioengineering 2019Quote: ... The peptides were passed through Illustra Microspin G25 columns (GE Healthcare) to remove TCO-PEG3-maleimide.
-
bioRxiv - Molecular Biology 2023Quote: Peptide pulldowns were performed using Streptavidin High Performance beads (GE Healthcare) and either RIPA or EBC buffer ...
-
bioRxiv - Microbiology 2020Quote: ... of each peptide was serially diluted 2-fold in a 1:10 dilution of phosphate-buffered saline (PBS) (Hyclone; GE Healthcare, Pittsburgh, PA) in dH2O (10%PBS) ...
-
bioRxiv - Biochemistry 2020Quote: ... Membranes were blocked in 2% ECL Prime™ Blocking Agent (GE Healthcare, RPN418) in TBST (Tris-Buffered Saline (Bio-Rad ...
-
bioRxiv - Molecular Biology 2019Quote: ... The sample was fractionated on Superdex Peptide PC3.2/30 column (GE Healthcare) at a flow rate of 50 µl/min of 30% ACN ...
-
bioRxiv - Molecular Biology 2020Quote: ... followed by gel-filtration chromatography on Superdex Peptide 10/300 (GE Healthcare) in Buffer A.
-
bioRxiv - Cell Biology 2019Quote: MTED peptide was coupled to cyanogen bromide-activated Sepharose beads (GE Healthcare). 30μM porcine brain tubulin was incubated with either peptide-coated or uncoated Sepharose beads in BRB80 ...
-
bioRxiv - Biophysics 2022Quote: ... the sample was passed through Superdex peptide 10/300GL column (GE healthcare); connected to Biologic Duoflow model Bio-Rad fast protein liquid chromatography (FPLC ...